Publications by authors named "Svetlana Mustafina"
We aimed to analyze the profile of glucose lowering therapy (GLT) in persons with diabetes mellitus type 2 (DM2) in an aging Russian population. A random population sample (n = 3898, men/women, 55−84) was examined in Novosibirsk, during 2015−2018 (HAPIEE Project). The design of the present work is a cross-sectional study.
View Article and Find Full Text PDFThe paper presents findings on the kinetic regularities of polyisoprene production in the presence of neodymium-based catalytic systems for large-scale production processes. A mathematical model has been developed for batch and continuous isoprene polymerization. The study identified dependences of changes in the number-average and mass-average molecular weight of the resulting product on the length of the applied reactor cascade under continuous static operation.
View Article and Find Full Text PDFBackground: The COVID-19 lockdown has had a significant impact on mental health. Patients with eating disorders (ED) have been particularly vulnerable.
Aims: (1) To explore changes in eating-related symptoms and general psychopathology during lockdown in patients with an ED from various European and Asian countries; and (2) to assess differences related to diagnostic ED subtypes, age, and geography.
Article Synopsis
- * Findings: Significant risk factors for T2DM included high BMI, abdominal obesity, fasting hyperglycemia, high triglycerides, hypertension, and family history of diabetes. Secondary education, low physical activity, and cardiovascular disease history were also notable for females.
- * Tool Development: A T2DM risk calculator was created based on simple, non-laboratory parameters like waist circumference, hypertension history, and family diabetes history, providing an effective way to identify individuals at
Objective: To investigate whether bright light treatment can reduce body mass in overweight subjects irrespective of their seasonal (= light) dependence.
Methods: A crossover, placebo-controlled, randomized clinical trial was performed between November and April in Novosibirsk, Russia (55° N). The trial comprised a 3-week in-home session of morning bright light treatment using a device of light-emitting diodes and a 3-week placebo session by means of a deactivated ion generator, separated by an off-protocol period of at least 23 days.